COPD as a Lung Disease with Systemic Consequences – Clinical Impact, Mechanisms, and Potential for Early Intervention
暂无分享,去创建一个
Thierry Troosters | Marc Decramer | Sanjay Sethi | Christopher B Cooper | D. Mannino | M. Decramer | E. Wouters | S. Rennard | T. Troosters | C. Cooper | S. Sethi | N. Giardino | Nicholas Giardino | Emiel Wouters | Stephen Rennard | D. Mapel | David Mannino | Douglas W Mapel
[1] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[2] Kazuhisa Miyashita,et al. Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. , 2006, European journal of public health.
[3] P. Jones,et al. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. , 2000, Respiratory medicine.
[4] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[5] W. Katon,et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. , 2001, General hospital psychiatry.
[6] D. Klein,et al. Smoking and panic attacks: an epidemiologic investigation. , 1999, Archives of general psychiatry.
[7] M C Neale,et al. Smoking and major depression. A causal analysis. , 1993, Archives of general psychiatry.
[8] M. Decramer,et al. Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats , 2005, Circulation.
[9] Thierry Troosters,et al. Physical activity and hospitalization for exacerbation of COPD. , 2006, Chest.
[10] J. Bourbeau,et al. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis , 2006, Thorax.
[11] N. Hanania,et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.
[12] J. Polivy,et al. Dieting and binging. A causal analysis. , 1985, The American psychologist.
[13] N. Chavannes,et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.
[14] E. Wouters,et al. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. , 1999, Clinical nutrition.
[15] S. Spencer,et al. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.
[16] H. Beckwitt,et al. Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types. , 1968, The American journal of medicine.
[17] B. Steele,et al. Correlates of Physical Activity in Chronic Obstructive Pulmonary Disease , 2001, Nursing research.
[18] D. Mellström,et al. Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. , 2007, The Journal of clinical endocrinology and metabolism.
[19] S. M. Lee,et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.
[20] R. Ziegler,et al. Reduced Pulmonary Function in Patients with Spinal Osteoporotic Fractures , 1998, Osteoporosis International.
[21] R. Casaburi,et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[22] K. Westerterp,et al. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[23] E. Wouters,et al. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. , 2000, The American journal of clinical nutrition.
[24] Everett M. Rogers,et al. Consensus Development Conference , 1984 .
[25] A. Granata,et al. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. , 2006, European journal of endocrinology.
[26] N. Anthonisen,et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. , 2003, JAMA.
[27] H. Chrystyn,et al. Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.
[28] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[29] C. Jenkins,et al. The TORCH (TOwards a Revolution in COPD Health) survival study protocol , 2004, European Respiratory Journal.
[30] M. Tsukino,et al. Longitudinal deteriorations in patient reported outcomes in patients with COPD. , 2007, Respiratory medicine.
[31] D. Sin,et al. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.
[32] F. Maltais,et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. , 2005, Journal of cardiopulmonary rehabilitation.
[33] T. Seemungal,et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.
[34] E. Wouters,et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.
[35] D. Mannino,et al. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination , 2003, Journal of internal medicine.
[36] B. J. Zebb,et al. The catastrophic misinterpretation of physiological distress. , 1999, Behaviour research and therapy.
[37] S. Nolen-Hoeksema,et al. Explaining the gender difference in depressive symptoms. , 1999, Journal of personality and social psychology.
[38] N. Anthonisen,et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.
[39] Thierry Troosters,et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.
[40] Amir Sharafkhaneh,et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. , 2006, Psychosomatics.
[41] W. Kannel,et al. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. , 1989, The American review of respiratory disease.
[42] E. Wouters,et al. Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. , 2004, Clinical nutrition.
[43] L. Forkert,et al. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. , 2002, Chest.
[44] Ja. Chronic Obstructive Pulmonary Disease , 1986 .
[45] B. Make,et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.
[46] S. Suissa,et al. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD , 2005, European Respiratory Journal.
[47] S. Mody,et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD , 2007, European Respiratory Journal.
[48] P. Yellowlees,et al. Psychiatric morbidity in patients with life‐threatening asthma: initial report of a controlled study , 1988, The Medical journal of Australia.
[49] F. Dekker,et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants , 2002, Thorax.
[50] B. Nordestgaard,et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.
[51] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[52] D. Górecka,et al. Smokers with airway obstruction are more likely to quit smoking , 2006, Thorax.
[53] John E Connett,et al. Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.
[54] B. Celli,et al. Exercise Endurance in COPD Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and , 2006 .
[55] D. Mannino,et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study , 2003, Thorax.
[56] S. Rennard,et al. Rescue! Therapy and the paradox of the Barcalounger , 2003, European Respiratory Journal.
[57] J. Roca,et al. Training Depletes Muscle Glutathione in Patients with Chronic Obstructive Pulmonary Disease and Low Body Mass Index , 2006, Respiration.
[58] D. Hansell,et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. , 2005, American journal of respiratory and critical care medicine.
[59] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[60] M. Tsukino,et al. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. , 2005, Chest.
[61] X. Busquets,et al. Enhanced neutrophil response in chronic obstructive pulmonary disease , 2001, Thorax.
[62] S. Rennard,et al. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. , 1992, The American journal of physiology.
[63] Christer Janson,et al. Anxiety and Depression are Related to the Outcome of Emergency Treatment in Patients with Obstructive Pulmonary Disease. , 2002, Chest.
[64] L. Wollin,et al. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. , 2005, American journal of respiratory and critical care medicine.
[65] S. Morzorati,et al. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala , 1995, Brain Research.
[66] S. Johnston,et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.
[67] E. Wouters,et al. Are patients with COPD psychologically distressed? , 2005, European Respiratory Journal.
[68] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[69] X. Busquets,et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[70] F. Maltais,et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. , 2005, Chest.
[71] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[72] C. Vogelmeier,et al. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[73] R. White,et al. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. , 1999, Journal of cardiopulmonary rehabilitation.
[74] A. Yohannes,et al. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire , 2000, International journal of geriatric psychiatry.
[75] M. Hyland,et al. A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.
[76] Andrew H. Miller,et al. Neuropsychiatric Adverse Effects of Interferon-α , 2005 .
[77] D. Niewoehner. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. , 2006, The American journal of medicine.
[78] D. Coultas,et al. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. , 2000, Archives of internal medicine.
[79] D. Rainnie,et al. The Amygdala, Panic Disorder, and Cardiovascular Responses , 2003, Annals of the New York Academy of Sciences.
[80] Cotes Je,et al. LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.
[81] K. Lorig,et al. Effect of a self-management program on patients with chronic disease. , 2001, Effective clinical practice : ECP.
[82] T. Wilt,et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). , 2005, Evidence report/technology assessment.
[83] J. Yzermans,et al. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review , 1999, Thorax.
[84] Y. Schutz,et al. The cost of breathing in stable chronic obstructive pulmonary disease. , 1995, Clinical science.
[85] J. Compston,et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (WHO Technical Report Series No 843) , 1995 .
[86] D. V. van Thiel,et al. Nutritional status and lung function in patients with emphysema and chronic bronchitis. , 1983, Chest.
[87] Hunter Am,et al. The nutritional status of patients with chronic obstructive pulmonary disease. , 1981 .
[88] M. Vest,et al. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. , 1992, Behaviour research and therapy.
[89] B. Celli,et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. , 2006, Chest.
[90] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[91] J. Wedzicha,et al. Ambulatory oxygen for chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.
[92] L. Wehren. The epidemiology of osteoporosis and fractures in geriatric medicine. , 2003, Clinics in geriatric medicine.
[93] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[94] W. Bailey,et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.
[95] G. Prigatano,et al. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. , 1984, Archives of internal medicine.
[96] F. Karatas,et al. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. , 2004, Clinical and investigative medicine. Medecine clinique et experimentale.
[97] Tamara B Harris,et al. Daily activity energy expenditure and mortality among older adults. , 2006, JAMA.
[98] B. Kayahan,et al. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. , 2006, Respiratory medicine.
[99] François Maltais,et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[100] M. Decramer,et al. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.
[101] B. Make,et al. Treatments for COPD. , 2005, Respiratory medicine.
[102] J. Greenleaf,et al. Effects of 3-day bed rest on physiological responses to graded exercise in athletes and sedentary men. , 2001, Journal of applied physiology.
[103] G. Verleden,et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[104] S. Quintana,et al. Mortality after hospitalization for COPD. , 2002, Chest.
[105] Fernando Holguin,et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.
[106] I. Pavord,et al. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[107] C. Rochester. IMPROVEMENT IN EXERCISE TOLERANCE WITH THE COMBINATION OF TIOTROPIUM AND PULMONARY REHABILITATION IN PATIENTS WITH COPD , 2005 .
[108] D. Mannino,et al. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. , 1997, American journal of respiratory and critical care medicine.
[109] D. O’Donnell,et al. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD , 2006, Thorax.
[110] W. MacNee,et al. Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.
[111] M. Decramer,et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.
[112] W. Bailey,et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. , 2004, American journal of respiratory and critical care medicine.
[113] K R Westerterp,et al. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. , 1997, Thorax.
[114] B. Celli,et al. Pulmonary rehabilitation and the BODE index in COPD , 2005, European Respiratory Journal.
[115] A. Foresi,et al. Effect of heliox breathing on dynamic hyperinflation in COPD patients. , 2004, Chest.
[116] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .
[117] A Senthilselvan,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.
[118] F. Maltais,et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. , 2003, Archives of internal medicine.
[119] F. Maltais,et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[120] S. Gordon,et al. Waging war on modern chronic diseases: primary prevention through exercise biology , 2000, Journal of applied physiology.
[121] C. D. Mathers,et al. Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.
[122] M. Belman,et al. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[123] John Connett,et al. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.
[124] T. Keistinen,et al. The COPD-induced hospitalization burden from first admission to death. , 2007, Respiratory medicine.
[125] C. Dulberg,et al. Relationship of lung function to severity of osteoporosis in women. , 1990, The American review of respiratory disease.
[126] X. Busquets,et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[127] Mitchell Rs,et al. CHRONIC OBSTRUCTIVE BRONCHOPULMONARY DISEASE. I. CLINICAL FEATURES. , 1964 .
[128] A. Buist,et al. The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.
[129] D. O’Donnell,et al. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[130] Is 12-hour oxygen as effective as 24-hour oxygen in advanced chronic obstructive pulmonary disease with hypoxemia? (The nocturnal oxygen therapy trial--NOTT) , 1980, Chest.
[131] K. Engedal,et al. High prevalence of anxiety symptoms in hospitalized geriatric patients , 2001, International journal of geriatric psychiatry.
[132] B. Celli,et al. Gender and COPD in patients attending a pulmonary clinic. , 2006, Chest.
[133] Florent Richy,et al. Strategies for the prevention of hip fracture. , 2003, The American journal of medicine.
[134] D. Mannino,et al. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Respiratory care.
[135] C. Cooper. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. , 2006, The American journal of medicine.
[136] M. Lebowitz,et al. Death certificate reporting of confirmed airways obstructive disease. , 1991, American journal of epidemiology.
[137] John R Hurst,et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[138] X. Busquets,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[139] T. De,et al. Parenteral nutrition before gastrointestinal surgery. , 1982 .
[140] F. Forastiere,et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. , 1997, The European respiratory journal.
[141] J. Wedzicha,et al. COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.
[142] P. Kannus,et al. Osteoporotic fractures of the proximal humerus in elderly Finnish persons: Sharp increase in 1970-1998 and alarming projections for the new millennium , 2000, Acta orthopaedica Scandinavica.
[143] A. Rifkin,et al. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. , 1990, The American journal of psychiatry.
[144] Andrew H. Miller,et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. , 2005, CNS drugs.
[145] R. Zuwallack,et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. , 2003, Chest.
[146] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[147] J. Lammers,et al. Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD. , 2006, Respiratory medicine.
[148] H. Kopera,et al. Briefe an die Redaktion , 1989, Klinische Wochenschrift.
[149] Victor F. Froelicher,et al. Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.
[150] M. Decramer,et al. Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift Trial , 2004, COPD.
[151] E. R. Sutherland,et al. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis , 2003, Thorax.
[152] R. Stockley,et al. NEUTROPHILS FROM SUBJECTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE SHOW ENHANCED CHEMOTAXIS AND EXTRACELLULAR PROTEOLYSIS , 1987, The Lancet.
[153] A. Anzueto,et al. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. , 2005, Pulmonary pharmacology & therapeutics.
[154] M. Decramer,et al. Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.
[155] M. Maes,et al. Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.
[156] E. Wouters,et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.
[157] K. P. Van de Woestijne,et al. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. , 1967, The American review of respiratory disease.
[158] R. Stockley,et al. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype? , 2006, Respiratory research.
[159] M. Bugiani,et al. Predictors of survival in a group of patients with chronic airflow obstruction. , 1998, Journal of clinical epidemiology.
[160] D. Sin,et al. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. , 2003, The American journal of medicine.
[161] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[162] D. O’Donnell,et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[163] E. Wouters. Local and systemic inflammation in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[164] D. Niewoehner,et al. Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.
[165] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[166] M. Decramer,et al. CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .
[167] C. Rosen,et al. A rational approach to evidence gaps in the management of osteoporosis. , 2005, The American journal of medicine.
[168] P. Palange,et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. , 2004, Journal of applied physiology.
[169] E. Wouters,et al. Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.
[170] S. Cummings,et al. Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. , 2005, The Journal of clinical endocrinology and metabolism.
[171] N. Keim,et al. The prevalence and determinants of nutritional changes in chronic obstructive pulmonary disease. , 1984, Chest.
[172] E. Culham,et al. Thoracic Kyphosis, Rib Mobility, and Lung Volumes in Normal Women and Women With Osteoporosis , 1994, Spine.
[173] X. Busquets,et al. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease]. , 2002, Archivos de bronconeumologia.
[174] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[175] R. Casaburi,et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. , 2006, Chest.
[176] D. Tashkin. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. , 2006, The American journal of medicine.
[177] D. Mannino,et al. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. , 2003, Archives of internal medicine.
[178] H. Besedovsky,et al. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.
[179] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[180] P. Calverley,et al. Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.
[181] D. Bates,et al. Prevention of Exacerbations of Chronic Obstructive , 2005 .
[182] A. Ionescu,et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[183] P. Young,et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study , 2002, European Respiratory Journal.
[184] Steven De Peuter,et al. Dyspnea: the role of psychological processes. , 2004, Clinical psychology review.
[185] J. Nurnberger,et al. Is cholinergic sensitivity a genetic marker for the affective disorders? , 1994, American journal of medical genetics.
[186] D. Postma,et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. , 2006, Respiratory medicine.
[187] Helle Bruunsgaard,et al. Physical activity and modulation of systemic low‐level inflammation , 2005, Journal of leukocyte biology.
[188] C. Cooper,et al. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease , 2005, BMJ : British Medical Journal.
[189] Thierry Troosters,et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[190] J. Barberà,et al. Effects of Endurance Training on Skeletal Muscle Bioenergetics in Chronic Obstructive Pulmonary Disease , 1999 .
[191] Abdullah Alsaeedi,et al. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. , 2002, The American journal of medicine.
[192] D. Mannino,et al. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. , 2006, Respiratory medicine.
[193] McDonald,et al. Depression and Chronic Obstructive Pulmonary Disease: Treatment Trials. , 1998, Seminars in clinical neuropsychiatry.
[194] Andrus Viidik,et al. Age and gender differences in negative affect—Is there a role for emotion regulation? , 2005 .
[195] G. FitzGerald,et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.
[196] C. Prefaut,et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? , 2004, American journal of respiratory and critical care medicine.
[197] C. Nemeroff,et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. , 2001, The American journal of psychiatry.
[198] R. Teague,et al. Correlates of daily impairment in COPD. , 1988 .
[199] M. Sullivan,et al. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. , 1996, Thorax.
[200] S. Powers,et al. Mechanisms of disuse muscle atrophy: role of oxidative stress. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[201] Z. Nahas,et al. Functional impairment in COPD patients: the impact of anxiety and depression. , 2000, Psychosomatics.
[202] M. Mador,et al. Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. , 2001, American journal of respiratory and critical care medicine.
[203] J. Stockman,et al. Mortality in Relation to Smoking: 50 Years' Observations on Male British Doctors , 2006 .
[204] N. Hanania,et al. The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD , 2003 .
[205] F. Blasi,et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. , 2006, Respiratory medicine.
[206] J. Wedzicha,et al. Causes of death in patients with COPD and chronic respiratory failure. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[207] J. Barberà,et al. Mitochondrial dysfunction in COPD patients with low body mass index , 2007, European Respiratory Journal.
[208] G. Eifert,et al. The effects of running and meditation on beta-endorphin, corticotropin-releasing hormone and cortisol in plasma, and on mood , 1995, Biological Psychology.
[209] B. Celli,et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study , 2006, Health and quality of life outcomes.
[210] Elizabeth M. Borycki,et al. Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention , 2003 .
[211] T. Similowski,et al. The potential impact of anaemia of chronic disease in COPD , 2006, European Respiratory Journal.
[212] M. Render,et al. Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease. , 1993, The American journal of medicine.
[213] D. O’Donnell,et al. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[214] B. Lipworth. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease , 2005, The Lancet.
[215] E. Wouters,et al. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[216] J. Barberà,et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[217] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[218] M. Decramer,et al. Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.
[219] G. Filley,et al. CHRONIC OBSTRUCTIVE BRONCHOPULMONARY DISEASE. I. CLINICAL FEATURES. , 1964, The American review of respiratory disease.
[220] S. Rennard,et al. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. , 1992, The American journal of physiology.
[221] J. Zieliński,et al. Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.
[222] E. Wouters,et al. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function , 1998, European Journal of Clinical Nutrition.
[223] A. Silman,et al. The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[224] Y. Lacasse,et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[225] J. Kanis,et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.
[226] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[227] S. Anker,et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. , 2005, Chest.
[228] Harry K. Genant,et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.
[229] K. Kubo,et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. , 1998, The American journal of physiology.
[230] F. Maltais,et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD , 2000, Thorax.
[231] F. Sériès,et al. Upper airway mucosa temperature in obstructive sleep apnoea/hypopnoea syndrome, nonapnoeic snorers and nonsnorers. , 1998, The European respiratory journal.
[232] S. Kivelä,et al. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. , 1997, Respiration; international review of thoracic diseases.
[233] Susan R. Johnson,et al. Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.
[234] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.